NPCE (STOCKS)
Neuropace, Inc. Common Stock
$14.880000
+0.620000 (+4.35%)
Prev close: $14.260000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Joel D. Becker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $500.63M
- Employees
- 209
- P/E (TTM)
- -22.55
- P/B (TTM)
- 25.16
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.08 | $-0.15 | +0.0745 | +48.22% |
|
Sep 2025 (Q3)
|
$-0.11 | $-0.20 | +0.0902 | +45.05% |
|
Jun 2025 (Q2)
|
$-0.26 | $-0.23 | -0.0330 | -14.54% |
|
Mar 2025 (Q1)
|
$-0.21 | $-0.25 | +0.0363 | +14.74% |
Financial Statements
| Revenues | $99.99M |
| Benefits Costs and Expenses | $0.00 |
| Cost Of Revenue | $22.77M |
| Costs And Expenses | $116.32M |
| Gross Profit | $77.22M |
| Operating Expenses | $93.56M |
| Research and Development | $27.89M |
| Other Operating Expenses | $65.67M |
| Operating Income/Loss | -$16.34M |
| Income/Loss From Continuing Operations After Tax | -$21.47M |
| Income/Loss From Continuing Operations Before Tax | $99.99M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$21.47M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$21.47M |
| Net Income/Loss Available To Common Stockholders, Basic | -$21.47M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.66 |
| Diluted Earnings Per Share | -$0.66 |
| Basic Average Shares | 32,722,438 |
| Diluted Average Shares | 32,722,438 |
| Assets | $105.57M |
| Current Assets | $94.07M |
| Cash | $61.10M |
| Inventory | $16.90M |
| Other Current Assets | $16.08M |
| Noncurrent Assets | $11.49M |
| Fixed Assets | $1.13M |
| Other Non-current Assets | $10.37M |
| Liabilities | $86.53M |
| Current Liabilities | $17.81M |
| Accounts Payable | $2.22M |
| Wages | $10.49M |
| Other Current Liabilities | $5.11M |
| Noncurrent Liabilities | $68.72M |
| Equity | $19.03M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $19.03M |
| Liabilities And Equity | $105.57M |
| Net Cash Flow From Operating Activities | -$11.01M |
| Net Cash Flow From Operating Activities, Continuing | -$11.01M |
| Net Cash Flow From Investing Activities | -$332.00K |
| Net Cash Flow From Investing Activities, Continuing | -$332.00K |
| Net Cash Flow From Financing Activities | $19.60M |
| Net Cash Flow From Financing Activities, Continuing | $19.60M |
| Net Cash Flow | $8.26M |
| Net Cash Flow, Continuing | $8.26M |
| Comprehensive Income/Loss | -$21.47M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$21.47M |
| Other Comprehensive Income/Loss | $0.00 |